Mexiletine is a medication used to treat irregular heartbeats, and it has been on the market for over 35 years. It is generally considered to be a safe and effective drug, but as with any medication, there can be unexpected side effects. In this article, we will explore the potential unforeseen side effects of Mexiletine and what doctors should look out for when prescribing it.
Mexiletine is a type of antiarrhythmic drug, which means it is used to treat irregular heartbeats, or arrhythmias. It works by blocking the sodium channels in the heart, which helps to regulate the electrical activity in the heart and restore a normal rhythm. It is commonly used to treat ventricular arrhythmias, which are arrhythmias that originate in the lower chambers of the heart.
Like any medication, Mexiletine can have potential side effects. The most common side effects are nausea, vomiting, dizziness, and fatigue. It can also cause an abnormal heart rate, which can be dangerous. Other potential side effects include headaches, constipation, blurred vision, and dry mouth.
In addition to the more common side effects, there have been some reports of more serious and unexpected side effects from Mexiletine. These side effects include allergic reactions, liver and kidney damage, and even sudden death.
There have been some reports of allergic reactions to Mexiletine, which can range from mild to severe. Symptoms of an allergic reaction can include hives, rash, itching, swelling, difficulty breathing, and dizziness. If you experience any of these symptoms while taking Mexiletine, contact your doctor immediately.
There have also been reports of liver and kidney damage due to Mexiletine. This is especially concerning, as the liver and kidneys are responsible for filtering out toxins from the body. If these organs are damaged, it can lead to a buildup of toxins in the body, which can be dangerous.
There have also been reports of sudden death due to Mexiletine. This is extremely rare, but it is still important to be aware of the possibility. If you experience any signs of an arrhythmia, such as chest pain or shortness of breath, contact your doctor immediately.
When prescribing Mexiletine, it is important for doctors to be aware of the potential side effects, both common and unexpected. They should also monitor their patients closely for any signs of an allergic reaction, liver or kidney damage, or an arrhythmia.
Mexiletine is a medication used to treat irregular heartbeats, and it is generally considered to be a safe and effective drug. However, there have been some reports of more serious and unexpected side effects, such as allergic reactions, liver and kidney damage, and even sudden death. It is important for doctors to be aware of these potential side effects when prescribing Mexiletine, and to monitor their patients closely for any signs of these side effects.
1.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
2.
Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.
3.
AI catches one-third of interval breast cancers missed at screening
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
1.
Lymphomatoid Papulosis: What You Need to Know
2.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
3.
The Rise of Immunotherapy: New Advances in Cancer Treatment
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
Patient Management Following Organ-Preserving Cancer Interventions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation